GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Im Cannabis IMCC · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.63

-1.80%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Im Cannabis

Its shares trade under the ticker IMCC. It has been listed since 20 May 2020. In the fiscal year to 31 December 2025, it reported revenue of $38.4m and a net loss of $7.9m. At that date it held total assets of $22.3m and shareholders' equity of −$602,186.

IM Cannabis Corp. engages in importation, distribution and sale of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and full-spectrum cannabis extracts under the IMC, BLKMT, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Vancouver, Canada.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Biotechnology
Listed since
20 May 2020
Employees
2
Head office
KIBBUTZ GLIL YAM, CENTRAL DISTRICT, L3, 4690500
Incorporated in
A1
Classification
Medicinal Chemicals & Botanical Products
Filer status
Non-accelerated filer<br>Emerging growth company

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • IM Cannabis Corp. operates in the Health Care sector with a focus on medical cannabis products in Israel and Germany.
  • The company has a product portfolio including dried flowers and full-spectrum cannabis extracts under the IMC, BLKMT, and LOT420 brands.
  • IM Cannabis Corp. serves medical patients through its distribution and sale of medical cannabis products.

Weaknesses

  • IM Cannabis Corp. has only two employees, indicating a very small operational team.
  • The company's IPO occurred in May 2020, suggesting it is a relatively new public company with limited market history.
  • IM Cannabis Corp. is headquartered in Vancouver, Canada, which may limit its operational scope to specific regions.

Opportunities

  • Expanding into additional countries within the Health Care sector could increase market reach.
  • Growing demand for medical cannabis products in Israel and Germany presents a market opportunity.
  • The company's brands IMC, BLKMT, and LOT420 could be leveraged for further market penetration.

Threats

  • Regulatory changes in Israel and Germany could impact the importation and distribution of medical cannabis.
  • Competition from other medical cannabis providers in Israel and Germany may reduce market share.
  • The small employee count of two may hinder the company's ability to respond to market changes.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.